Clinical Pharmacology and Biopharmaceutics are two interconnected fields that play crucial roles in understanding drug actions and optimizing drug therapy. Clinical pharmacology focuses on the study of how drugs interact with the human body, encompassing aspects such as pharmacokinetics, pharmacodynamics, and pharmacogenomics. It examines how drugs are absorbed, distributed, metabolized, and eliminated within the body, considering factors such as age, genetics, and disease states that may influence drug responses. Biopharmaceutics, on the other hand, delves into the scientific principles underlying drug delivery and formulation, aiming to optimize drug bioavailability and therapeutic efficacy. It investigates the physicochemical properties of drugs and their formulations, as well as the mechanisms governing drug release and absorption. The integration of clinical pharmacology and biopharmaceutics is essential for designing effective drug therapies. Biopharmaceutical factors such as drug solubility, permeability, and formulation influence drug absorption and bioavailability, which in turn impact drug concentrations at the site of action and subsequent pharmacological responses. Understanding these factors allows clinicians to optimize drug dosing regimens and select appropriate formulations to achieve desired therapeutic outcomes. Moreover, clinical pharmacology principles guide the interpretation of drug concentration data and help predict individual patient responses to treatment based on factors such as metabolism and drug interactions.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States